/assets/production/practices/85712525cbb13cb741126a3f58199392b5630985/images/2677727.jpeg)
Xeomin is a neuromodulating product very similar to Botox Cosmetic. It is made by a different company and while the effect on the muscle, it’s duration of effect and dosing are nearly the same, there are a couple differences.
Mainly, Xeomin is a purified protein product. That means there are no other ingredients like proteins are additives which makes it less likely that a patient will develop a resistance to its effect and a great choice for any patients who are developing a resistance to Botox. At Kessel Dermatology, servicing the Hamilton Square, Trenton, and Mercer County areas in New Jersey, we offer this treatment as an alternative to Botox.

Xeomin® (incobotulinumtoxinA) is a prescription neuromodulator used to temporarily improve the appearance of moderate to severe frown lines between the eyebrows in adults.
Like other botulinum toxin type A treatments, Xeomin works by temporarily reducing the muscle contractions that contribute to expression lines.
When you frown or squint, the muscles between your eyebrows contract, causing the overlying skin to repeatedly fold.
Over time, as the skin loses some of its elasticity, these repeated contractions can contribute to lines that remain visible even when your face is at rest.
Xeomin acts on the nerve endings that signal targeted muscles to contract. By temporarily reducing these contractions, the overlying skin is given an opportunity to smooth and frown lines become less noticeable.
Xeomin contains incobotulinumtoxinA, a purified form of botulinum toxin type A.
One of the primary differences between Xeomin and some other neuromodulators is its formulation. Xeomin is manufactured without the accessory proteins found in certain other botulinum toxin products.
Although neuromodulators work in similar ways, they are not identical or interchangeable unit for unit. Product selection and dosing should be based on your individual anatomy, muscle strength, previous treatment experience, and desired result.
Yes. Xeomin received FDA approval for the temporary improvement of moderate to severe glabellar lines, commonly known as frown lines or “11s,” in adults in 2011.
Its safety and effectiveness for this indication were evaluated in randomized, placebo-controlled clinical trials before FDA approval.
Xeomin is FDA approved cosmetically for moderate to severe frown lines between the eyebrows.
Botulinum toxin products may also be used in other facial areas when medically and aesthetically appropriate. Uses outside of the FDA-approved indication are considered off-label.
Your treatment areas and dosing will be determined according to your anatomy, muscle movement, and aesthetic goals.
Successful neuromodulator treatment depends on much more than the product selected.
Facial anatomy, muscle strength, muscle recruitment patterns, eyebrow position, dosing, and injection placement all influence the result.
Our aesthetic medicine expert, Savy Guthrie, MPAS, PA-C, has over 20 years of dermatology experience and extensive experience performing cosmetic injectable treatments.
Treatment is customized to your individual anatomy with an emphasis on balanced, natural-looking results.
Before receiving Xeomin, tell your provider about your medical history and all medications, vitamins, and supplements you take.
Be sure to tell us if you:
If you have previously received a neuromodulator elsewhere, let us know which product was used, when you received it, and, if known, the dose administered.
Xeomin offers another neuromodulator option for patients looking to soften expression lines while maintaining a natural appearance.
The choice between Xeomin, BOTOX Cosmetic, or another treatment depends on your anatomy, treatment history, muscle movement, and individual goals.
Schedule an aesthetic consultation at Kessel Dermatology to determine whether Xeomin is appropriate for you.